07:22 AM EDT, 04/18/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, PRESIDENT AND CEO, on April 16, 2024, sold 100,000 shares in ARS Pharmaceuticals ( SPRY ) for $928,005. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 12,546,116 shares of the company, with 4,126,822 shares held directly and 8,419,294 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924011055/xslF345X03/form4-04172024_100434.xml